NCT00854126View on ClinicalTrials.gov

A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Non-Hodgkin's Lymphoma, Solid Cancers

Interventions

DRUG

GDC-0980

Escalating repeating dose

Trial Locations (3)

94805

Villejuif

02115

Boston

M20 4BX

Manchester

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY